Connect Biopharma Holdings Ltd. (CNTB)
NASDAQ · Healthcare
Connect Biopharma Holdings Ltd. annual/quarterly total liabilities history from 2023 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Connect Biopharma Holdings Ltd. total liabilities for the quarter ending December 31, 2025 were 14.1M, a 54.58% increase year-over-year.
- Connect Biopharma Holdings Ltd. total liabilities for 2025 were 14.1M, a 54.58% increase from 2024.
- Connect Biopharma Holdings Ltd. total liabilities for 2024 were 9.1M, a 64.77% decrease from 2023.
- Connect Biopharma Holdings Ltd. total liabilities for 2023 were 25.9M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Connect Biopharma Holdings Ltd. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $14 |
| 2024 | $9 |
| 2023 | $26 |
| Connect Biopharma Holdings Ltd. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $14 |
| 2024-12-31 | $9 |
| 2023-12-31 | $26 |
Connect Biopharma Holdings Ltd. Total Liabilities — FAQ
Connect Biopharma Holdings Ltd. (CNTB) total liabilities over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CNTB's total liabilities history?
The chart and table above show Connect Biopharma Holdings Ltd.'s total liabilities by year and by quarter, including the growth rate.